An epidemic of depression or the medicalization of distress?

Perspectives in Biology and Medicine

Volumn 51, Issue 2, 2008, Pages 238-250

  Mulder, Roger T ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

COGNITION; COGNITIVE THERAPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DISTRESS SYNDROME; DRUG INDUSTRY; EPIDEMIC; EVIDENCE BASED MEDICINE; HUMAN; INCIDENCE; LIFESTYLE; MAJOR DEPRESSION; MEDICAL RESEARCH; PHYSICIAN; PRIORITY JOURNAL; REVIEW; SOCIAL ASPECT; SUICIDE; WORLD HEALTH ORGANIZATION;

DEPRESSIVE DISORDER, MAJOR; DRUG INDUSTRY; EVIDENCE-BASED MEDICINE; HUMANS; INCIDENCE; MEDICINE; MENTAL HEALTH SERVICES; PSYCHIATRIC STATUS RATING SCALES; SICK ROLE; STRESS, PSYCHOLOGICAL; SUICIDE; WORLD HEALTH;

EID: 43449113562     PISSN: 00315982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. American Psychiatric Association (APA). 1990. Diagnostic and statistical manual of mental disorders, 4th ed. (DSM-IV). Washington, DC: APA.
2. Andrews, G. 2001. Should depression be managed as a chronic disease? BMJ 322(7283): 419-21.
3. Andrews, G., S. Henderson, and W. Hall. 2001. Prevalence, comorbidity, disability and service utilisation: Overview of the Australian National Mental Health Survey. Br J Psychiatry 178:145-53.
4. Angst, F., et al. 2002. Mortality of patients with mood disorders: Follow-up over 34-38 years. J Affect Disord 68(2-3):167-81.
5. Beautrais, A. L., et al. 1996. Prevalence and comorbidity of mental disorders in persons making serious suicide attempts: A case-control study. Am J Psychiatry 153(8):1009-14.
6. Beyond Blue. 2000. The National Depression Initiative, Australia.
7. Blazer, D., et al. 1988. Depressive symptoms and depressive diagnoses in a community population. Use of a new procedure for analysis of psychiatric classification. Arch Gen Psychiatry 45(12):1078-84.
8. Brown, W. A., M. F. Johnson, and M. G. Chen. 1992. Clinical features of depressed patients who do and do not improve with placebo. Psychiatry Res 41(3):203-14.
9. Brugha, T. S., et al. 1992. Antidepressants may not assist recovery in practice: A naturalistic prospective survey. Acta Psychiatr Scand 86(1):5-11.
10. Burton, R. 1621. The anatomy of melancholy. London.
11. Carroll, B. J. 1982. Use of the dexamethasone suppression test in depression. J Clin Psychiatry 43(11 pt. 2):44-50.
12. Franklin, C. L., D. R. Strong, and R. L. Greene. 2002. A taxometric analysis of the MMPI-2 depression scales. J Pers Assess 79(1):110-21.
13. Goldberg, D., et al. 1998. The effects of detection and treatment on the outcome of major depression in primary care: A naturalistic study in 15 cities. Br J Gen Pract 48(437): 1840-44.
14. Healy, D. 2004. Let them eat Prozac: The unhealthy relationship between the pharmaceutical industry and depression. New York: New York Univ. Press.
15. Hickie, I. 1996. Issues in classification. III. Utilising behavioural constructs in melancholia research. In Melancholia: A disorder of movement and mood, ed G. Parker and D. Hadiz-Pavlovic, 38-56. New York: Cambridge Univ. Press.
16. Hirschfeld, R. M., et al. 1997. The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA 277(4):333-40.
17. Horowitz, A. V. 2002. Creating mental illness. Chicago: Univ. of Chicago Press.
18. Hunter, R., and I. Macalpine. 1974. Psychiatry for the Poor: 1851 Colney Hatch Asylum-Friern Hospital 1973. Folkestone: Dawsons.
19. Jorm, A. F., et al. 2002. Effectiveness of complementary and self-help treatments for depression. Med J Aust 176(suppl.):S84-S96.
20. Kendler, K. S., and C. O. Gardner, Jr. 1998. Boundaries of major depression: An evaluation of DSM-IV criteria. Am J Psychiatry 155(2):172-77.
21. Kessler, D., et al. 1999. Cross sectional study of symptom attribution and recognition of depression and anxiety in primary care. BMJ 318:436-39.
22. Kessler, R. C. 2002. The categorical versus dimensional assessment controversy in the sociology of mental illness. J Health Soc Behav 43(2):171-88.
23. Kessler, R. C., and R. G. Frank. 1997. The impact of psychiatric disorders on work loss days. Psychol Med 27(4):861-73.
24. Khan, A., et al. 2002. Severity of depression and response to antidepressants and placebo: An analysis of the Food and Drug Administration database. J Clin Psychopharmacol 22(1):40-45.
25. Korkeila, J., et al. 2007. Use of antidepressants and suicide rate in Finland: an ecological study. J Clin Psychiatry 68(4):505-11.
26. Kupfer, D. J., and M. E. Thase. 1983. The use of the sleep laboratory in the diagnosis of affective disorders. Psychiatr Clin North Am 6(1):3-25.
27. Lexchin, J. 1993. Interactions between physicians and the pharmaceutical industry: What does the literature say? CMAJ 149(10):1401-7.
28. Moncrieff, J. 2006. Psychiatric drug promotion and the politics of neoliberalism. Br J Psychiatry 188(4):301-2.
29. Moynihan, R., I. Heath, and D. Henry. 2002. Selling sickness: The pharmaceutical industry and disease mongering. BMJ 324(7342):886-91.
30. Mulder, R. T. 1992. Boundaries of psychiatry. Perspect Biol Med 35(3):443-59.
31. Murray, C. J., and Lopez, A. D., eds. 1996. The global burden of disease. Cambridge: Harvard School of Public Health.
32. National Institute for Clinical Excellence (NICE). 2004. Depression: Management of depression in primary and secondary care. Clinical practice guideline no. 23. London: NICE.
33. Parker, G. 2005. Beyond major depression. Psychol Med 35(4):467-74.
34. Paykel, E. S. 1971. Classification of depressed patients: A cluster analysis derived grouping. Br J Psychiatry 118(544):275-88.
35. Pilgrim, D., and R. Bentall. 1999. The medicalisation of misery: A critical realist analysis of the concept of depression. J Ment Health 8(3):261-74.
36. Porter, R. J., and P. Gallagher. 2006. Abnormalities of the HPA axis in affective disorders: Clinical subtypes and potential treatments. Acta Neuropsychiatrica 18:193-209.
37. Regier, D. A., et al. 1988. The NIMH Depression Awareness, Recognition, and Treatment Program: Structure, aims, and scientific basis. Am J Psychiatry 145(11):1351-57.
38. Rice, D. P., and L. S. Miller. 1995. The economic burden of affective disorders. Br J Psychiatry Suppl 27:34-42.
39. Ronalds, C., et al. 1997. Outcome of anxiety and depressive disorders in primary care. Br J Psychiatry 171:427-33.
40. Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Depression. 2004. Australian and New Zealand clinical practice guidelines for the treatment of depression. Aust NZ J Psychiatry 38:389-407.
41. Ruscio, J., and A. M. Ruscio. 2000. Informing the continuity controversy: A taxometric analysis of depression. J Abnorm Psychol 109(3):473-87.
42. Ruscio, J., and A. M. Ruscio. 2002. A structure-based approach to psychological assessment: Matching measurement models to latent structure. Assessment 9(1):4-16.
43. Safer, D. J., and J. M. Zito. 2007. Do antidepressants reduce suicide rates? Public Health 121(4):274-77.
44. Sanderson, K., et al. 2003. Reducing the burden of affective disorders: Is evidence-based health care affordable? J Affect Disord 77:109-25.
45. Slade, T., and G. Andrews. 2005. Latent structure of depression in a community sample: A taxometric analysis. Psychol Med 35(4):489-97.
46. Spiker, D. G., and D. J. Kupfer. 1988. Placebo response rates in psychotic and nonpsychotic depression. J Affect Disord 14(1):21-23.
47. Sullivan, P. F., R. C. Kessler, and K. S. Kendler. 1998. Latent class analysis of lifetime depressive symptoms in the national comorbidity survey. Am J Psychiatry 155(10):1398-1406.
48. Tiihonen, J., et al. 2006. Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort. Arch Gen Psychiatry 63(12):1358-67.
49. Üstün, B., and N. Sartorius, eds. 1995. Mental illness in general health care: An international study. Chichester: John Wiley.
50. van Praag, H. M. 1992. Reconquest of the subjective. Against the waning of psychiatric diagnosing. Br J Psychiatry 160:266-71.
51. van Praag, H. M. 1993. "Make-believes" in psychiatry or the perils of progress. New York: Brunner/Mazel.
52. Waller, N. G., and P. E. Meehl. 1998. Multivariate taxometric procedures: Distinguishing types from continua. Thousand Oaks, CA: Sage.
53. Wazana, A. 2000. Physicians and the pharmaceutical industry: Is a gift ever just a gift? JAMA 283(3):373-80.
54. Weissman, M. M., et al. 1996. Cross-national epidemiology of major depression and bipolar disorder. JAMA 276(4):293-99.
55. WHO World Mental Health Survey Consortium. 2004. Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization world mental health surveys. JAMA 291(21):2581-90.
56. World Health Organization (WHO). 2007. Depression. http://www.who.int/ mental_health/management/depression/definition/en/.